Development and validation of a risk prediction model for acute care use among older advanced cancer patients on clinical trials
JNCI: Journal of the National Cancer Institute · 2025
DOI: 10.1093/jnci/djaf342 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2025. Verfasst von Dawn L Hershman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Columbia University Medical Center, New York, NY, United States. Hauptthemen laut MEDLINE: Neoplasms, Emergency Service, Hospital, Hospitalization. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIH/NCI.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background patients with advanced cancer are at risk for unplanned Emergency Department (ED) visits and hospital stays (HS). The purpose was to develop and validate a risk prediction model to identify patients at the highest risk for acute care use.
Methods
We identified advanced cancer patients ≥65 years treated on SWOG trials from 1999-2014 using data linked to Medicare claims. The primary outcome was acute care use (ED visits or HS). A 60% random sample training set was used to identify candidate variables. An adverse risk model was built by summing adverse factors and creating high vs low-risk groups by splitting at the median. This risk model was tested in the 40% validation set.
Results
Among N = 1397 patients from 6 trials, 839 comprised the training set. The proportion of patients with ≥1 HS/ED visit was 67.5%. Adverse risk factors were performance status (0 vs.≥1), coronary artery disease, hypertension, and liver disease. Patients with ≥2 factors (high-risk; 57.3%) vs. 0/1 risk factor (low-risk; 42.7%) were more likely to experience acute care (79.6% vs. 51.1%), corresponding to a > 3-fold increase in odds (OR = 3.38, 95%CI , 2.48-4.62). Results were similar in the test set, indicating successful validation. Among all patients, quartile-level proportions were 48.9% for zero risk factors vs. 84.0% for 3/4 risk factors. The C-statistic was 0.703.
Conclusions
A limited set of 4 variables predicted a threefold increased risk of acute care use in older patients with advanced cancer. Personalized interventions aimed at preventing acute care use could improve the quality of cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Columbia University Medical Center, New York, NY, United States.
- SWOG Statistics and Data Management Center, Seattle, WA, United States.
- Fred Hutch Cancer Center, Seattle, WA, United States.
ORCID-Profile: Dawn L Hershman, Cathee Till, Scott Ramsey, Joseph M Unger
Förderung
- NCI NIH HHS
- NIH/NCI
Zitieren
APA
Hershman, D. L., Till, C., LeBlanc, M., Ramsey, S., & Unger, J. M. (2025). Development and validation of a risk prediction model for acute care use among older advanced cancer patients on clinical trials. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf342
Vancouver
Hershman DL, Till C, LeBlanc M, Ramsey S, Unger JM. Development and validation of a risk prediction model for acute care use among older advanced cancer patients on clinical trials. JNCI: Journal of the National Cancer Institute. 2025. doi:10.1093/jnci/djaf342
BibTeX
@article{Hershman2025,
author = {Hershman, Dawn L and Till, Cathee and LeBlanc, Michael and Ramsey, Scott and Unger, Joseph M},
title = {Development and validation of a risk prediction model for acute care use among older advanced cancer patients on clinical trials},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2025},
doi = {10.1093/jnci/djaf342}
}
EUVIMED